Giansun Precision Technology Group
001400
Heilongjiang Tianyouwei Electronics
603202
Joy Kie Corporation
300994
4
Kingchem
301509
5
Hunan Er-kang Pharmaceutical
300267
(Q3)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total operating revenue | 24.10%1.16B | 10.87%3.44B | 5.16%2.53B | -4.78%1.71B | -10.77%930.81M | -64.54%3.1B | -70.02%2.41B | -69.32%1.8B | -68.79%1.04B | -34.55%8.74B |
Operating revenue | 24.22%1.15B | 11.14%3.43B | 5.62%2.53B | -4.29%1.71B | -10.21%928.36M | -64.46%3.09B | -69.95%2.39B | -69.29%1.79B | -68.83%1.03B | -34.48%8.69B |
Other operating revenue | ---- | ---- | ---- | -15.25%647.67M | ---- | ---- | ---- | -36.04%764.22M | ---- | -22.83%1.82B |
Interest income | -19.93%1.96M | -49.64%6.97M | -64.46%5.62M | -69.55%4.11M | -73.39%2.45M | -76.57%13.85M | -77.69%15.82M | -72.56%13.49M | -63.76%9.19M | -43.47%59.09M |
Total operating cost | 20.34%1.11B | -5.40%3.88B | -9.55%2.9B | -22.06%1.83B | -29.60%921.46M | -61.12%4.1B | -60.28%3.2B | -60.26%2.34B | -60.40%1.31B | -22.48%10.55B |
Operating cost | 36.77%730.6M | 23.69%2.17B | 16.32%1.58B | -0.60%1.03B | -11.58%534.18M | -73.53%1.75B | -72.92%1.36B | -72.93%1.04B | -72.61%604.1M | -24.86%6.62B |
Operating tax surcharges | -18.65%27.05M | -7.75%108.38M | -7.81%83.22M | -13.72%64.66M | -10.62%33.25M | -2.67%117.48M | -4.01%90.27M | 7.65%74.94M | 7.56%37.2M | -25.52%120.7M |
Operating expense | -15.42%235.62M | -19.45%1.18B | -20.70%882.8M | -30.31%565.99M | -38.82%278.57M | -49.14%1.46B | -50.20%1.11B | -46.89%812.1M | -44.90%455.35M | -22.35%2.87B |
Administration expense | 21.12%43.71M | -12.39%205.03M | 22.26%198.92M | -22.32%85.47M | -38.51%36.08M | -27.22%234.02M | -31.64%162.7M | -29.95%110.03M | -29.82%58.68M | -13.16%321.56M |
Financial expense | 100.12%67.73M | -61.03%200.77M | -71.53%129.9M | -76.94%68.77M | -77.09%33.84M | -12.83%515.24M | 2.52%456.35M | 0.00%298.26M | -0.59%147.7M | 9.88%591.11M |
-Interest expense (Financial expense) | 90.03%69.72M | -59.08%214.66M | -70.37%137.89M | -75.93%73.25M | -75.42%36.69M | -10.72%524.61M | 5.19%465.37M | 1.75%304.32M | -3.24%149.25M | 6.86%587.63M |
-Interest Income (Financial expense) | -2.61%-1.29M | 9.87%-8.88M | 66.02%-3.72M | 76.16%-2.08M | 76.99%-1.26M | 36.14%-9.85M | -2.98%-10.96M | -14.15%-8.72M | -8.03%-5.47M | 17.47%-15.42M |
Research and development | -24.12%4.21M | -2.02%22.54M | -2.29%16.89M | -4.36%11.08M | -4.25%5.54M | -5.33%23.01M | -5.38%17.29M | -6.24%11.59M | -3.20%5.79M | -9.69%24.3M |
Credit Impairment Loss | 188.22%1.24M | 29.89%-32.18M | -5.88%-5.1M | -149.89%-2.06M | 60.33%-1.41M | -188.06%-45.9M | -202.30%-4.82M | 957.91%4.13M | -3,566.21%-3.54M | 14.90%-15.93M |
Asset Impairment Loss | 99.79%-738.98 | 1.09%-418.64M | 88.15%-59.72K | 87.87%-39.8K | -126.81%-357.98K | -30.29%-423.26M | 18.00%-503.81K | 26.52%-328.07K | 29.34%-157.84K | -324.49%-324.86M |
Other net revenue | 197.49%83.9M | 483.43%2.05B | 537.83%2.51B | -82.37%59.72M | -88.26%28.2M | -616.37%-533.6M | 374.82%393.2M | 470.12%338.7M | 4,512.72%240.2M | -76.93%103.34M |
Fair value change income | ---- | -3.74%-521.09M | ---- | ---- | ---- | -771.64%-502.29M | ---6.5M | ---790.5K | ---200.8K | -397.87%-57.63M |
Invest income | 2,599.75%69.59M | 1,738.47%2.9B | 1,319.41%2.43B | -98.58%2.46M | -98.51%2.58M | 1,440.17%157.87M | 7,818.43%171M | 24,942.58%173.19M | 10,972.79%173.44M | -97.39%10.25M |
-Including: Investment income associates | 91.88%-5.34K | 100.24%7.9K | 101.05%31.1K | 63.34%-187.04K | 76.92%-65.76K | 25.88%-3.27M | 14.52%-2.97M | 75.87%-510.21K | 76.04%-284.91K | 77.09%-4.42M |
Asset deal income | -50.97%12.42M | -54.54%118.48M | -62.79%84.11M | -64.72%55.04M | -61.99%25.33M | -43.48%260.61M | 430.23%226.02M | 269.03%156.04M | 4,163.54%66.64M | 567.93%461.09M |
Other revenue | -68.76%642.77K | -115.49%-3M | -78.51%1.72M | -33.00%4.32M | -48.82%2.06M | -36.31%19.37M | -76.45%7.99M | -62.83%6.45M | -28.23%4.02M | -51.19%30.42M |
Operating profit | 246.56%130.12M | 204.48%1.6B | 633.71%2.14B | 74.46%-52.16M | 247.36%37.55M | 9.92%-1.53B | -901.31%-401.57M | -760.39%-204.27M | -160.09%-25.48M | -969.75%-1.7B |
Add:Non operating Income | 45.51%8.37M | 26.11%15.29M | 295.00%11.91M | 68.08%9.06M | 52.30%5.75M | -78.84%12.13M | -93.08%3.02M | -84.01%5.39M | -50.27%3.78M | 34.98%57.31M |
Less:Non operating expense | -97.10%37.78K | -25.80%250.71M | -72.45%55.88M | -88.87%19.01M | -98.66%1.3M | -47.70%337.88M | 293.95%202.82M | 698.26%170.86M | 1,498.07%97.43M | 144.26%646M |
Total profit | 229.68%138.45M | 173.53%1.37B | 449.07%2.1B | 83.20%-62.11M | 135.25%41.99M | 18.84%-1.86B | -1,525.65%-601.38M | -954.77%-369.74M | -371.40%-119.14M | -8,676.16%-2.29B |
Less:Income tax cost | -15.84%13.87M | 547.17%141.2M | 73.29%70.03M | -88.83%8.18M | 167.49%16.48M | -90.03%21.82M | 371.01%40.41M | 690.04%73.22M | -372.50%-24.42M | 56.61%218.85M |
Net profit | 388.25%124.58M | 165.18%1.23B | 416.18%2.03B | 84.13%-70.29M | 126.94%25.52M | 25.05%-1.88B | -2,009.89%-641.78M | -1,403.29%-442.96M | -371.12%-94.72M | -1,414.07%-2.51B |
Net profit from continuing operation | 388.25%124.58M | 165.18%1.23B | 416.18%2.03B | 84.13%-70.29M | 126.94%25.52M | 25.05%-1.88B | -2,009.89%-641.78M | -1,403.29%-442.96M | -371.12%-94.72M | -1,414.07%-2.51B |
Less:Minority Profit | 4.76%5.54M | 143.54%15.16M | -2.34%9.67M | 17.10%7.58M | 5.20%5.29M | -73.86%6.22M | -36.82%9.9M | -46.97%6.47M | -27.00%5.02M | 30.37%23.81M |
Net profit of parent company owners | 488.44%119.04M | 164.16%1.21B | 409.89%2.02B | 82.68%-77.86M | 120.28%20.23M | 25.50%-1.89B | -3,734.69%-651.69M | -2,162.98%-449.43M | -455.53%-99.75M | -1,276.81%-2.54B |
Earning per share | ||||||||||
Basic earning per share | 300.00%0.04 | 164.29%0.45 | 409.86%0.7511 | 83.02%-0.09 | 108.33%0.01 | 77.05%-0.7 | -1,222.22%-0.2424 | -1,866.67%-0.53 | -500.00%-0.12 | -1,286.36%-3.05 |
Diluted earning per share | 300.00%0.04 | 164.29%0.45 | 409.86%0.7511 | 83.02%-0.09 | 108.33%0.01 | 77.05%-0.7 | -1,222.22%-0.2424 | -1,866.67%-0.53 | -500.00%-0.12 | -1,286.36%-3.05 |
Other composite income | 106.19%225.51K | 59.82%-32.89M | 57.35%-39.38M | 76.09%-21.14M | 95.38%-3.65M | -182.94%-81.85M | -624.24%-92.35M | -521.30%-88.41M | -4,122.63%-78.95M | -90.47%98.69M |
Other composite income of parent company owners | 106.19%225.51K | 59.82%-32.89M | 57.35%-39.38M | 76.09%-21.14M | 95.38%-3.65M | -182.94%-81.85M | -624.24%-92.35M | -521.30%-88.41M | -4,122.63%-78.95M | -89.90%98.69M |
Total composite income | 470.66%124.81M | 160.79%1.19B | 371.05%1.99B | 82.79%-91.43M | 112.59%21.87M | 18.59%-1.96B | -1,533.33%-734.13M | -1,066.61%-531.36M | -570.66%-173.68M | -377.56%-2.41B |
Total composite income of parent company owners | 619.14%119.27M | 159.83%1.18B | 366.14%1.98B | 81.59%-99M | 109.28%16.59M | 19.13%-1.97B | -2,193.23%-744.03M | -1,357.52%-537.83M | -695.29%-178.7M | -407.36%-2.44B |
Total composite income of minority owners | 4.76%5.54M | 143.54%15.16M | -2.34%9.67M | 17.10%7.58M | 5.20%5.29M | -73.86%6.22M | -36.82%9.9M | -46.97%6.47M | -27.00%5.02M | -68.88%23.81M |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
Auditor | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.